CareDx (CDNA) Tops Q4 EPS by 11c, provides guidance

CareDx (NASDAQ: CDNA) reported Q4 EPS of $0.12, $0.11 better than the analyst estimate of $0.01. Revenue for the quarter came in at $108 million versus the consensus estimate of $102.18 million.

GUIDANCE:

CareDx sees FY2026 revenue of $420-444 million, versus the consensus of $417.7 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• AeroVironment restates quarterly financials, citing $89M goodwill error
• JPMorgan Starts BSE Limited (BSE:IN) at Neutral